Max Robotics — Global Service Robot Directory + US Certification

About

Silvio Caringi is a pioneering surgeon at the forefront of robotic hepatobiliary and pancreatic surgery, with a focused expertise in minimally invasive treatments for primary and metastatic liver cancers. His major contributions center on advancing the safety, standardization, and oncological adequacy of robotic procedures, particularly for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA). Notably, his multicenter case series on robotic liver resection for HCC (8 citations) demonstrates reduced postoperative complications without compromising oncologic outcomes. Caringi has also been instrumental in standardizing complex techniques, such as his step-by-step description of robotic pancreatoduodenectomy, which addresses barriers to widespread adoption. His work extends to evaluating robotic surgery in special populations, including obese patients and those with breast cancer liver metastases, using propensity score-matched analyses. With a meta-analysis on R1 vascular margins in minimally invasive liver surgery (2026), he is shaping evidence-based guidelines for oncologic adequacy. His scoping review of the da Vinci Single-Port platform in general surgery highlights his forward-looking approach to reducing surgical footprints. Through these contributions, Caringi is redefining the possibilities of robotic surgery, making complex procedures safer and more accessible for patients worldwide.